In vivo administration of a nuclear transcription factor-κB decoy suppresses experimental crescentic glomerulonephritis

Journal of the American Society of Nephrology

Volumn 11, Issue 7, 2000, Pages 1244-1252

  Tomita, Naruya ^a   Morishita, Ryuichi ^a   Lan, Hui Y ^b   Yamamoto, Kei ^a   Hashizume, Masahide ^c   Notake, Mitsue ^c   Toyosawa, Kaoru ^c   Fujitani, Buichi ^c   Mu, Wei ^b   Nikolic Paterson, David J ^b   Atkins, Robert C ^b   Kaneda, Yasufumi ^a   Higaki, Jitsuo ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b MONASH MEDICAL CENTRE   (Australia)

^c DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; OLIGODEOXYNUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; GLOMERULONEPHRITIS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY INJURY; LEUKOCYTE ADHERENCE; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEINURIA; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; RAT;

EID: 0034050031     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Kerr PG, Lan HY, Atkins RC: Rapidly progressive glomerulonephritis. In: Diseases of the Kidney, edited by Schrier RW, Gottschalk CW, Boston, Little, Brown & Co., 1996, pp 1619-1644
2. Hooke DH, Gee DC, Atkins RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31: 964-972, 1987
3. Li H-L, Hancock WW, Dowling JP, Atkins RC: Activated (IL-2R+) intraglomerular mononuclear cells in crescentic glomerulonephritis. Kidney Int 39: 793-798, 1991
4. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R: In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 43: 682-692, 1993
5. Ma L, Yang B, Nikolic-Paterson DJ, Chen Y, Atkins RC, Wang H: Intercellular adhesion molecule-1 and tumour necrosis factor-α expression in human glomerulonephritis. Nephrology 3: 329-337, 1997
6. Niemir ZI, Stein H, Dworacki G, Mundel P, Koehl N, Koch B, Autschbach F, Andrassy K, Ritz E, Waldherr R, Otto HF: Podocytes are the major source of IL-1α and IL-1β in human glomerulonephritides. Kidney Int 52: 393-403, 1997
7. Rovin BH, Doe N, Tan LC: Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis 27: 640-646, 1996
8. Muller GA, Markovski-Lipkovski J, Muller CA: Intercellular adhesion molecule-1 expression in human kidneys with glomerulonephritis. Clin Nephrol 36: 203-208, 1991
9. Schreiner GF, Cotran RS, Pardo V, Unanue ER: A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med 147: 369-384, 1978
10. Lan HY, Nikolic-Paterson DJ, Zarama M, Vannice JL, Atkins RC: Suppression of experimental glomerulonephritis by the IL-1 receptor antagonist. Kidney Int 43: 479-485, 1993
11. Lan HY, Nikolic-Paterson DJ, Mu W, Vannice JL, Atkins RC: Interleukin-1 receptor antagonist halts the progression of established rat crescentic glomerulonephritis in the rat. Kidney Int 47: 1303-1309, 1995
12. Tang WW, Feng L, Vannice JL, Wilson CB: Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. J Clin Invest 93: 273-279, 1994
13. Hruby ZW, Shirota K, Jothy S, Lowry RP: Antiserum against tumor necrosis factor-α and a protease inhibitor reduce immune glomerular injury. Kidney Int 40: 43-51, 1991
14. Lan HY, Yang N, Metz C, Mu W, Song Q, Nikolic-Paterson DJ, Bacher M, Bucala R, Atkins RC: TNF-α upregulates renal MIF expression in rat crescentic glomerulonephritis. Mol Med 3: 136-144, 1997
15. Lenardo MJ, Baltimore D: NF-κB: A pleiotropic mediator of inducible and tissue specific gene control. Cell 58: 227-229, 1989
16. Barnes PJ, Karin M: Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997
17. Tomita N, Horiuchi M, Tomita S, Gibbons GH, Kim JY, Baran D, Dzau VJ: An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro. Am J Physiol 275: F278-F284, 1998
18. Morishita R, Gibbons GH, Horiuchi M, Ellison KE, Nakama M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ: A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc Natl Acad Sci USA 92: 5855-5859, 1995
19. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T: In vivo transfection of cis element decoy against nuclear factor-κB binding site prevents myocardial infarction. Nat Med 3: 894-899, 1997
20. Kaneda Y, Iwai K, Uchida T: Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243: 375-378, 1989
21. Tomita N, Higaki J, Kaneda Y, Yu H, Morishita R, Mikami H, Ogihara T: Hypertensive rats produced by in vivo introduction of the human renin gene. Circ Res 73: 898-905, 1993
22. Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ: Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest 91: 2580-2585, 1993
23. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, Dzau VJ: Evidence for direct local effect of angiotensin in vascular hypertrophy: In vivo gene transfer of angiotensin converting enzyme. J Clin Invest 94: 978-984, 1994
24. Tomita N, Higaki J, Morishita R, Kato K, Mikami H, Kaneda Y, Ogihara T: Direct in vivo gene introduction into rat kidney. Biochem Biophys Res Commun 186: 129-134, 1992
25. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet derived growth factor into the rat kidney. J Clin Invest 92: 2597-2601, 1993
26. Lan HY, Paterson DJ, Atkins RC: Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 40: 425-433, 1991
27. Sunderland CA, McMaster WR, Williams AF: Purification with monoclonal antibody of a predominant leukocyte-common antigen and glycoprotein from rat thymocytes. Eur J Immunol 9: 155-159, 1979
28. Tomita N, Morishita R, Higara J, Aoki M, Nakamura H, Fukamizu A, Murakami K, Kaneda Y, Ogihara T: Transient decrease in high blood pressure by in vivo transfer of antisense oligodeoxynucleotides against rat angiotensinogen. Hypertension 26: 131-136, 1995
29. Lan HY, Mu W, Yang N, Meinhardt A, Nikolic-Paterson DJ, Bacher M, Atkins RC, Bucala R: De novo renal expression of macrophage migration inhibitory factor (MIF) during the development of rat crescentic glomerulonephritis. Am J Pathol 149: 1119-1127, 1996
30. O'Neill LA, Greene C: Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants. J Leukocyte Biol 63: 650-657, 1998
31. Sakurai H, Shigemori N, Hisada Y, Ishizuka T, Kawashima K, Sugita T: Suppression of NF-κB and AP-1 activation by glucocorticoids in experimental glomerulonephritis in rats: Molecular mechanisms of anti-nephritic action. Biochim Biophys Acta 1362: 252-262, 1997
32. Morrissey JJ, Klahr S: Enalapril decreases nuclear factor κB activation in the kidney with ureteral obstruction. Kidney Int 52: 926-933, 1997
33. Nikolic-Paterson DJ, Lan HY, Hill PA, Vannice JL, Atkins RC: Suppression of experimental glomerulonephritis by the interleukin-1 receptor antagonist: Inhibition of intercellular adhesion molecule-1 expression. J Am Soc Nephrol 4: 1695-1700, 1994
34. Atkins RC, Nikolic-Paterson DJ, Lan HY: Tubulointerstitial injury in glomerulonephritis. Nephrology 2[Suppl 1]: S2-S6, 1996
35. Moullier P, Friedlander GF, Calise D, Ronco P, Perricaudet M, Ferry N: Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int 45: 1220-1225, 1994
36. Dinarello CA: Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 16: 457-499, 1998
37. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W: Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates established experimental colitis in mice. Nat Med 2: 998-1004, 1996